Ampla Pharmaceuticals
Stage
Series B | DeadTotal Raised
$9.12MLast Raised
$3.65MLoading...
Loading...
Ampla Pharmaceuticals Patents
Ampla Pharmaceuticals has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/13/2014 | 5/30/2017 | Athletic shoe brands, Sportswear brands, Shoe brands, Fluid dynamics, Aerodynamics | Grant |
Application Date | 8/13/2014 |
|---|---|
Grant Date | 5/30/2017 |
Title | |
Related Topics | Athletic shoe brands, Sportswear brands, Shoe brands, Fluid dynamics, Aerodynamics |
Status | Grant |
Ampla Pharmaceuticals Frequently Asked Questions (FAQ)
Where is Ampla Pharmaceuticals's headquarters?
Ampla Pharmaceuticals's headquarters is located at 184 High Street, Boston.
What is Ampla Pharmaceuticals's latest funding round?
Ampla Pharmaceuticals's latest funding round is Series B.
How much did Ampla Pharmaceuticals raise?
Ampla Pharmaceuticals raised a total of $9.12M.
Who are the investors of Ampla Pharmaceuticals?
Investors of Ampla Pharmaceuticals include Advent International, Integra Ventures and Crabtree Ventures.
Who are Ampla Pharmaceuticals's competitors?
Competitors of Ampla Pharmaceuticals include Paratek Pharmaceuticals, BioCogent, Elcelyx Therapeutics, Potentia Pharmaceuticals, Cempra Pharmaceuticals and 7 more.
Loading...
Compare Ampla Pharmaceuticals to Competitors
Abunda, is a stealth mode healthcare company incubated by Burrill & Company
Aurora Biomed is a biotechnology company
Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create human protein pharmaceuticals with enhanced therapeutic properties. Most protein pharmaceuticals are rapidly eliminated by the body, which limits their effectiveness and requires that they be administered by frequent, often daily, injection. The company's products are designed to last longer in the body, which aims to allow them to be administered less frequently, e.g., once per week to once per month, and maximizes their therapeutic benefits to patients. Company scientists combine protein structure/function information with targeted protein modification technologies to rationally design long-acting protein pharmaceuticals that, in many cases, are 10-100-fold more potent than competing products prepared using non-targeted protein modification technologies. Bolder BioTechnology has a robust pipeline of products in preclinical development, including products for the treatment of hematological and endocrine disorders, cancer and infectious disease. The company intend to commercialize these products independently and through strategic alliances with corporate partners.
Cellular Engineering Technologies is a biotechnology tissue engineering company.
Qwell Pharmaceuticals is a biotechnology company focused on small molecule development primarily for oncology indications.
Alice Therapeutics is a biotechnology company.
Loading...